Advancing Neurological Research: The Impact of the HEALTHY BRAINS Act

Advancing Neurological Research: The Impact of the HEALTHY BRAINS Act

As the Executive Director of the Coleen Cunningham Foundation for PSP Awareness, I am thrilled to share the significant progress in the fight against neurodegenerative diseases through the introduction of the HEALTHY BRAINS Act. This groundbreaking legislation, spearheaded by U.S. Representatives Jennifer Wexton (D-VA) and Gus Bilirakis (R-FL), aims to deepen our understanding of how environmental factors contribute to diseases like Progressive Supranuclear Palsy (PSP), Parkinson's, Alzheimer's, ALS, and Multiple Sclerosis.

Neurodegenerative diseases affect over 50 million people worldwide, causing devastating impacts on individuals and their families. As someone who has seen these effects firsthand, I understand the urgent need for comprehensive research into potential environmental risk factors, such as toxic chemical exposures, that may play a significant role in the development and progression of these diseases.

The HEALTHY BRAINS Act is a bipartisan effort that seeks to advance research by establishing Collaborative Centers for Neurodegenerative Disease Environmental Research. These centers, under the National Institutes of Health (NIH), will unite researchers, healthcare professionals, patients, caregivers, and nonprofit organizations in a concerted effort to investigate environmental risk factors and develop new strategies for prevention and treatment.

The introduction of this legislation is a vital step toward answering the common question many families face: "Could this disease have been caused by environmental exposures?" By understanding the relationship between environmental toxins and neurological conditions, we can work towards preventing these devastating diseases from occurring in the first place.

Moreover, the Act encourages the establishment of a nationwide neurodegenerative disease data system and a clearinghouse to enhance knowledge of environmental risks. This collaborative approach promises to accelerate critical research and foster educational opportunities, ensuring a national focus on brain health and environmental safety.

The HEALTHY BRAINS Act has garnered support from numerous influential organizations, including the American Academy of Neurology, the Michael J. Fox Foundation, the ALS Association, CurePSP, and many others. Their endorsement underscores the importance of this legislative effort in transforming our approach to neurodegenerative diseases.

Representative Wexton, diagnosed with PSP last year, has become a formidable advocate for brain health. Her leadership, alongside Congressman Bilirakis, has already brought significant legislative achievements, such as the National Plan to End Parkinson’s Act. Their continued dedication is an inspiration to all of us working in this field.

In conclusion, the HEALTHY BRAINS Act represents a monumental step forward in our quest to understand, treat, and eventually cure neurodegenerative diseases. At the Coleen Cunningham Foundation for PSP Awareness, we are committed to supporting this vital effort and collaborating with all stakeholders to make a meaningful impact on the lives of millions affected by these conditions. Together, we can work towards a future where families no longer have to fear the unknowns of these diseases and can look forward to a healthier, more informed world.

By Laura Louizos, Executive Director, Coleen Cunningham Foundation for PSP Awareness

Back to blog

3 comments

My eyes are not what they used to be.cant read sew or do alot of things,because of my eyes. Do have prism for close up but i dont need close up. I am near sited,which means i wear glasses for watching tv. I dont drive anymore. So i dont have to wear my glasses. But wear sunglasses outside with a prescription…. they are my close up prescription

Mirella Mammoliti

CBD OiÄş 5%,amd 0,2% of THC, would that be beneficial ,for PSP ?

Milan

Exciting news!

Tim Brown

Leave a public comment:

Please note, comments need to be approved before they are published.

  • Understanding Atypical Parkinsonism: PSP, MSA, CBD, and DLB

    Understanding Atypical Parkinsonism: PSP, MSA, ...

    Laura Louizos

    When we talk about Parkinsonism, most people immediately think of Parkinson's Disease (PD). However, there exists a group of less common disorders known as atypical parkinsonism, each with its unique...

    Understanding Atypical Parkinsonism: PSP, MSA, ...

    Laura Louizos

    When we talk about Parkinsonism, most people immediately think of Parkinson's Disease (PD). However, there exists a group of less common disorders known as atypical parkinsonism, each with its unique...

  • Introducing "Faces and Voices of Atypical Parkinsonism" by CCF

    Introducing "Faces and Voices of Atypical Parki...

    Laura Louizos

    At the Coleen Cunningham Foundation (CCF), we've embarked on a new journey to bring awareness to the lesser-known side of Parkinsonism - the atypical forms. Our latest campaign, "Faces and...

    Introducing "Faces and Voices of Atypical Parki...

    Laura Louizos

    At the Coleen Cunningham Foundation (CCF), we've embarked on a new journey to bring awareness to the lesser-known side of Parkinsonism - the atypical forms. Our latest campaign, "Faces and...

  • Understanding the Stages of Dementia with Lewy Bodies (DLB)

    Understanding the Stages of Dementia with Lewy ...

    Laura Louizos

    Dementia with Lewy Bodies (DLB) is a progressive neurodegenerative disorder characterized by cognitive decline, visual hallucinations, motor symptoms similar to Parkinson's disease, and fluctuating alertness. The progression of DLB can...

    Understanding the Stages of Dementia with Lewy ...

    Laura Louizos

    Dementia with Lewy Bodies (DLB) is a progressive neurodegenerative disorder characterized by cognitive decline, visual hallucinations, motor symptoms similar to Parkinson's disease, and fluctuating alertness. The progression of DLB can...

  • Understanding the Stages of Multiple System Atrophy (MSA)

    Understanding the Stages of Multiple System Atr...

    Laura Louizos

    Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder affecting several brain regions, resulting in symptoms related to movement, autonomic function, and sleep. Here's how the progression of MSA...

    Understanding the Stages of Multiple System Atr...

    Laura Louizos

    Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder affecting several brain regions, resulting in symptoms related to movement, autonomic function, and sleep. Here's how the progression of MSA...

1 of 4